Corient Private Wealth LLC Sells 59,449 Shares of MetLife, Inc. (NYSE:MET)

Corient Private Wealth LLC cut its holdings in shares of MetLife, Inc. (NYSE:MET) by 9.5% during the fourth quarter, Holdings Channel reports. The fund owned 569,553 shares of the financial services provider’s stock after selling 59,449 shares during the period. Corient Private Wealth LLC’s holdings in MetLife were worth $46,577,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Bank of New York Mellon Corp increased its stake in shares of MetLife by 109.2% in the fourth quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock valued at $722,727,000 after buying an additional 4,606,748 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in MetLife by 1.5% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock valued at $375,179,000 after acquiring an additional 68,579 shares in the last quarter. Nordea Investment Management AB lifted its position in shares of MetLife by 16.8% during the fourth quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock worth $347,735,000 after purchasing an additional 608,224 shares in the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of MetLife by 0.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,913,408 shares of the financial services provider’s stock valued at $320,430,000 after purchasing an additional 30,187 shares during the last quarter. Finally, Swedbank AB increased its holdings in shares of MetLife by 76.0% in the fourth quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock valued at $283,862,000 after purchasing an additional 1,496,645 shares in the last quarter. Institutional investors own 94.99% of the company’s stock.

MetLife Price Performance

NYSE MET opened at $82.23 on Tuesday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. The stock has a market cap of $56.02 billion, a price-to-earnings ratio of 13.77, a PEG ratio of 0.65 and a beta of 1.04. The business has a 50 day simple moving average of $83.45 and a 200 day simple moving average of $82.54. MetLife, Inc. has a 52-week low of $67.30 and a 52-week high of $89.05.

MetLife (NYSE:MET) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. Analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th were issued a $0.545 dividend. The ex-dividend date of this dividend was Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.65%. MetLife’s dividend payout ratio (DPR) is 36.52%.

Analyst Upgrades and Downgrades

A number of research analysts have commented on MET shares. Keefe, Bruyette & Woods decreased their price objective on MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 12th. JPMorgan Chase & Co. lifted their price objective on MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. TD Cowen upped their target price on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research report on Wednesday, November 27th. Cowen reiterated a “buy” rating on shares of MetLife in a research report on Friday, March 7th. Finally, Morgan Stanley increased their price objective on shares of MetLife from $101.00 to $109.00 and gave the company an “overweight” rating in a report on Friday, February 28th. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $94.58.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.